Fruquintinib combination with sintilimab in refractory metastatic colorectal cancer patients in China.

Gou, MM; Yan, H; Tie, EL; Wang, ZK; Si, HY; Chen, SY; Pan, YT; Fan, RJ; Qian, NS; Dai, GH

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):